To further dissect the molecular mechanism of JAM-A mAb, we found that 61H9G4 significantly inhibited IκBα and p65 protein phosphorylation, so it was possible that JAM-A mAb inhibited the NF-κB signaling pathway involved in the development of ESCC. The gene discussed is F11R; the disease is esophageal squamous cell carcinoma.